Sandra Calvin
Svp, Chief Accounting Officer at Travere Therapeutics, Inc. (TVTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 4,27543,453 held (−9%) | $62.14 | $266K | -16.1% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 80042,653 held (−2%) | $62.85 | $50K | -17.1% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 30042,353 held (−1%) | $63.66 | $19K | -18.1% |
| Apr 16SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 21,97742,353 held (−34%) | $41.07 | $903K | +26.9% |
| Feb 3SEC | TVTXTravere Therapeutics, Inc. | Sell | 4,33349,080 held (−8%) | $32.12 | $139K | +62.3% |
| Dec 29SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 7,40238,233 held (−16%) | $40.00 | $296K | +30.3% |
| Dec 16SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 2,91045,635 held (−6%) | $36.00 | $105K | +44.8% |
| Nov 6SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 67,11548,545 held (−58%) | $36.00 | $2.4M | +44.8% |
- Sell
Svp, Chief Accounting Officer Sandra Calvin sold $266K of TVTX at $62.14 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Chief Accounting Officer Sandra Calvin sold $50K of TVTX at $62.85 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Chief Accounting Officer Sandra Calvin sold $19K of TVTX at $63.66 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Chief Accounting Officer Sandra Calvin sold $903K of TVTX at $41.07 — cuts the stake by 34%; pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Chief Accounting Officer Sandra Calvin sold $296K of TVTX at $40.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp, Chief Accounting Officer Sandra Calvin sold $105K of TVTX at $36.00 — pre-scheduled 10b5-1 plan sale.